Calcium Dobesilate and Micro-vascular diseases.

Area of Science:

• Vascular Biology
• Pharmacology
• Diabetology

Background:

• Micro-vascular diseases pose global health challenges, causing organ damage via impaired blood flow.
• Diabetic microvascular complications, including retinopathy and nephropathy, significantly impact patient health.
• Calcium Dobesilate (CAD) is recognized for its vasoactive, angioprotective, antioxidant, and multitarget properties.

Purpose of the Study:

• To summarize the research progress on the clinical application of Calcium Dobesilate.
• To review the effectiveness, safety, and mechanisms of CAD in vascular injury-related diseases.
• To highlight new clinical effects of CAD observed in patients and animal models.

Main Methods:

• Review of experimental studies and animal models of diabetic microvascular complications.
• Analysis of clinical studies involving patients with micro-vascular damage-related diseases.
• Synthesis of research on the efficacy, safety, and mechanisms of Calcium Dobesilate.

Main Results:

• Calcium Dobesilate demonstrates significant improvement in symptoms of diabetic retinopathy and nephropathy.
• CAD exhibits antioxidant and vascular protective effects, beneficial in early disease stages.
• Studies indicate novel clinical effects and a favorable safety profile for CAD.

Conclusions:

• Calcium Dobesilate is a promising therapeutic agent for micro-vascular damage, particularly in diabetic complications.
• Further research supports the clinical application of CAD for vascular injury and related conditions.
• CAD's multitarget action and beneficial effects warrant its consideration in managing microvascular diseases.